Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Viorel Vasiliu
Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases
PLoS ONE
Multidisciplinary
Related publications
Prognostic Value of Immunohistochemical Markers in Stage Iii/Iv Classical Hodgkin Lymphoma Treated Frontline in the Lysa Eortc 20012 Randomized Protocol
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Significance of Immunohistochemical Markers in Glioma Patients
Prognostic Significance of Tryptophan Catabolism in Newly Diagnosed Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Evita: Phase I/Ii Study of Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group
Klinicka Onkologie
Oncology
Combination of Nivolumab and Bendamustine in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Lymphocyte-Rich Classical Hodgkin Lymphoma
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Circulating Dendritic Cells Deficiencies as a New Biomarker in Classical Hodgkin Lymphoma
British Journal of Haematology
Hematology
Suppressor of Cytokine Signaling 1 Gene Mutation Status as a Prognostic Biomarker in Classical Hodgkin Lymphoma
Oncotarget
Oncology
